Concurrent chemoradiotherapy plus adjuvant chemotherapy versus concurrent chemoradiotherapy in locoregionally advanced nasopharyngeal carcinoma-Reference-Cited by-同舟云学术

Concurrent chemoradiotherapy plus adjuvant chemotherapy versus concurrent chemoradiotherapy in locoregionally advanced nasopharyngeal carcinoma

Published:2016-05-23 Issue:6 Volume:192 Page:394-402
ISSN:0179-7158
Container-title:Strahlentherapie und Onkologie
language:en
Short-container-title:Strahlenther Onkol

Author:

Dong Yi-Yuan,Xiang Chun,Lu Jian-Xun,Su Yi-Xin,Pan Yu-Fei,Cai Rui,Zhang Rong-Jun,He Zhuo-Kai,Liu Mei-Lian,Huang Hui,Bai Xue,Tang Hua-Ying,Shi Yun-Hua,Wang Yan,Jiang Wei

Funder

The Scientific Research and Technology Development Program of Qinzhou

The Scientific Research and Technology Development Program of Guilin

The National Natural Science Foundation of China

The Guangxi National Natural Science Foundation

The Guangxi Medical Scientific Experiment Center Open Fund

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Radiology Nuclear Medicine and imaging

Link

http://link.springer.com/content/pdf/10.1007/s00066-016-0970-3.pdf

Reference30 articles.

1. Yu KH, Leung SF, Tung SY et al (2005) Survival outcome of patients with nasopharyngeal carcinoma with first local failure: a study by the Hong Kong Nasopharyngeal Carcinoma Study Group. Head Neck 27:397–405

2. Chen Y, Sun Y, Liang SB et al (2013) Progress report of a randomized trial comparing long-term survival and late toxicity of concurrent chemoradiotherapy with adjuvant chemotherapy versus radiotherapy alone in patients with stage III to IVB nasopharyngeal carcinoma from endemic regions of China. Cancer 119:2230–2238

3. Lee AW, Ng WT, Chan YH, Sze H, Chan C, Lam TH (2012) The battle against nasopharyngeal cancer. Radiother Oncol 104:272–278

4. Poplin EA, Benedetti JK, Estes NC et al (2005) Phase III Southwest Oncology Group 9415/Intergroup 0153 randomized trial of fluorouracil, leucovorin, and levamisole versus fluorouracil continuous infusion and levamisole for adjuvant treatment of stage III and high-risk stage II colon cancer. J Clin Oncol 23:1819–1825

5. Early Breast Cancer Trialists’ Collaborative Group (EBCTCG) (2005) Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet 365:1687–1717

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Concurrent chemoradiotherapy with additional chemotherapy for nasopharyngeal carcinoma: A pooled analysis of propensity score‐matching studies;Head & Neck;2021-02-28

2. The Current Role of Adjuvant Chemotherapy in Locally Advanced Nasopharyngeal Carcinoma;Frontiers in Oncology;2021-02-24

The Double-Edge Role of the Addition of Adjuvant Chemotherapy to Concurrent Chemoradiotherapy in the Treatment of Nasopharyngeal Carcinoma

;Cancer Management and Research;2020-02

4. Gemcitabine plus cisplatin versus fluorouracil plus cisplatin as a first-line concurrent chemotherapy regimen in nasopharyngeal carcinoma: a prospective, multi-institution, randomized controlled phase II study;Cancer Chemotherapy and Pharmacology;2019-05-13

5. Radiotherapy-induced dysphagia and its impact on quality of life in patients with nasopharyngeal carcinoma;Strahlentherapie und Onkologie;2019-01-28